Professor of Medicine, University of Chicago Medicine
Hematology
Dr. Suzanne D. Conzen, MD
|
|
Give Review
Suzanne D. Conzen works in the field of Hematology. He went to Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He has 3 awards "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Suzanne D. Conzen, MD is a published doctor and has 58 publications published. The lastest was: 'Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen.' He is registered with Medicare and accepts Medicare payments.
Publications
- Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast Cancer pathologic stage.
- Glucocorticoid receptor ChIP-sequencing of subcutaneous fat reveals modulation of inflammatory pathways.
- High resolution 3D MRI of mouse mammary Glands with intra-ductal injection of contrast media.
- Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.
- Aliphatic chain length by isotropic mixing (ALCHIM): determining composition of complex lipid samples by (1)H NMR spectroscopy.
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer.
- Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast Cancer.
- Chronic social isolation is associated with metabolic gene expression changes specific to mammary adipose tissue.
- The vanadyl chelate bis(acetylacetonato)oxovanadium(iv) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-d-glucose by cultured human Breast carcinoma cells.
- The role of adrenergic signaling in breast Cancer biology.
- The influence of glucocorticoid signaling on tumor progression.
- Phase II trial of temsirolimus in patients with metastatic breast Cancer.
- Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast Cancer.
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer.
- Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate Cancers.
- In vivo MRI of early stage mammary cancers and the normal mouse mammary Gland.
- Social isolation dysregulates endocrine and behaviOral stress while increasing malignant burden of spontaneous mammary tumors.
- Ductal Carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine ...
- A model of gene-environment interaction reveals altered mammary Gland gene expression and increased tumor growth following social isolation.
- Adaptive variation regulates the expression of the human SGK1 gene in response to stress.
- Administration of glucocorticoids to ovarian Cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues.
- Minireview: nuclear receptors and breast Cancer.
- Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.
- Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.
- Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast Cancer cells.
- Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
- Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast Cancer: results from two consecutive phase I/II trials.
- Mammary Cancer and social interactions: identifying multiple environments that regulate gene expression throughout the life span.
- Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast Cancer cell survival.
- Microarray Analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.
- Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells.
- Current status of selective estrogen receptor modulators (SERMs).
- Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1).
- Glucocorticoid receptor expression in breast Cancer associates with older patient age.
- A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway.
- Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.
- Dexamethasone inhibits TRAIL-induced apoptosis of thyroid Cancer cells via Bcl-xL induction.
- Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast Cancer.
- Detection of in situ mammary Cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.
- Invariant p53 immunostaining in primary and recurrent breast Cancer.
- Defective antigen presentation in chronically protein-deprived mice.
- The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
- Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived Breast cells.
- Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic Breast carcinoma.
- The PI 3-kinase/Akt signaling pathway deLivers an anti-apoptotic signal.
- Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen.
- The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells.
- Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis.
- Human breast Cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
- Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1.
- Expedition inspiration consensus 2001.
- Consensus statement: Expedition Inspiration fund for breast Cancer research meeting 2002.
- The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human Liver response to transplantation.
- The importance of transdisciplinary collaborations for understanding and resolving health disparities.
- In response to Dr. Formenti et al. (Int J Radiat Oncol Biol Phys 2005, 63:1275-1276).
- Magnetic resonance imaging of the natural history of in Situ mammary neoplasia in transgenic mice: a pilot study.
- A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data.
Schools
Yale University School Of Medicine
Mary Hitchcock Mem Hospital
Ny and Presby Hp Cornell Campus
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- HealthLink PPO
- Medicare MCR
- Sagamore Plus
- Samaritan Health Plans
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Dartmouth-Hitchcock Medical Center -
New York Presbyterian Hospital - Cornell Campus -
Yale University School of Medicine
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER | 1518029073 | |
| NPPES Provider LastName | CONZEN | |
| NPPES Provider FirstName | SUZANNE | |
| NPPES Provider ZIPCode | 605276686 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 143.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518029073 |
| Last Name Of The Provider | CONZEN |
| First Name Of The Provider | SUZANNE |
| View All |
Similar Doctors
|
|
Dr. Gini F. Fleming, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin Posadas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy Stock, MD |
|
|
Dr. Joseph M. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James E. Hannigan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerome I. Dickstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hedy L. Kindler, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard L. Schilsky, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark J. Ratain, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Everett E. Vokes, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Harry L. Messmore Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo J. Knaff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lucy A. Godley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Olufunmailyao Olopade, MD |
|
|
Dr. Christopher K. Daugherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brittany Beach
This Doctor is OpenDoctor Recommended.
|